| Value | ₹50.00 Cr |
|---|
NSE filing, NSE: GANDHAR. Summary written from the filing by ALFA Finder's alert engine.
Gandhar Oil Refinery (India) Ltd: key numbers
- Share price
- ₹248.75
- Market cap
- ₹2,435 Cr
- Revenue (annual)
- ₹4,241 Cr
- Net profit (annual)
- ₹135.4 Cr
- P/E (TTM)
- 5.5×Sector 17.8×
- Promoter holding
- 66.65%+0.05% QoQ
- FII holding
- 5.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gandhar Oil Refinery (India) Ltd
All →Gandhar Oil Refinery (India) Earnings Call Transcript: Key Takeaways
Gandhar achieved record quarterly revenue but margins and volumes face pressure from geopolitical disruptions and logistics costs.
- Call
- Guides 11% growth
Gandhar Oil Refinery (India) Investor Presentation: Key Takeaways
Record Q2 FY27 revenue ₹1,847 Cr (+73% YoY), EBITDA ₹288 Cr (15.6% margin), PAT ₹186 Cr. H1 revenue ₹3,579 Cr, PAT ₹392 Cr. Consolidated, unaudited.
Gandhar Oil Refinery (India) Results Update
Gandhar Oil posted record Q2 FY27 revenue of Rs 1,847 Crore, up 73%. Profit after tax rose to Rs 186 Crore, with margins sustained.
Gandhar Oil Refinery (India) Management Change
Gandhar Oil Refinery appointed Santosh Kumar Singh as Factory Manager of its Silvassa Plant, effective 27 October 2026. He is an existing employee currently serving as Assistant General Manager - Commercial.
Gandhar Oil Refinery (India) Q2 FY27 Results: Net Profit ₹186.3 Cr, Up 368.1% YoY
Gandhar Oil Refinery (India) Ltd reported revenue from operations of ₹1,847 Cr (+72.9% YoY) and net profit of ₹186.3 Cr (+368.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹186.3 Cr · +368.1% YoY
Gandhar Oil Refinery (India) Other Announcement
This filing presents the quarterly shareholding pattern for Gandhar Oil Refinery (India) Ltd for the period ending September 30, 2026.
Other merger & restructuring announcements
All →Vimta Labs Merger & Restructuring Worth ₹0.08 Cr
Vimta Labs incorporated wholly owned US subsidiary Vimta Labs LLC, investing about INR 0.08 Crore (USD 8,500). The contract research unit supports the parent's testing business.
- Value
- ₹0.08 Cr
Weagro Merger & Restructuring Worth ₹0.01 Cr
Weagro will incorporate a wholly-owned Singapore subsidiary, Weagro Pte Ltd, with initial investment up to SGD 100,000. The move expands its agro business into Singapore.
- Value
- ₹0.01 Cr
- Execution
- Within two months from the date of the Board decision, subject to statutory approvals.
Tejassvi Aaharam Merger & Restructuring
Tejassvi Aaharam (now WEAGRO) approved a wholly-owned subsidiary in Singapore and a Dubai branch office. The initial investment is up to SGD 100,000.
- Execution
- Within two months from the board decision, subject to statutory approvals
Ginni Filaments Merger & Restructuring
Ginni Filaments incorporated a wholly owned subsidiary, Ginni RSA (Pty) Ltd, in South Africa. The subsidiary will trade and distribute wet wipes internationally.
Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr
Thyrocare agreed to sell its entire stake in subsidiary Nueclear Healthcare to Trovera. The consideration is about Rs 141.40 Crore, including preference shares and cash.
- Value
- ₹141.4 Cr
Skipper Merger & Restructuring Worth ₹0.48 Cr
Skipper Limited incorporated a wholly owned subsidiary, Skipper Gridtech Inc, in Texas, USA. The subsidiary's share capital is up to USD 50,000 (about Rs 0.48 Crore).
- Value
- ₹0.48 Cr